Arrowgrass Capital Partners (US)’s Eli Lilly LLY Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$7.89M	Hold	60,000	–	–	2.07%	17
2019 Q3	$6.71M	Hold	60,000	–	–	0.5%	57
2019 Q2	$6.65M	Hold	60,000	–	–	0.16%	167
2019 Q1	$7.79M	Buy	+60,000	New	+$7.3M	0.23%	135
2018 Q1	–	Sell	-462,200	Closed	-$39M	–	322
2017 Q4	$39M	Buy	462,200 +456,578	+8,121%	+$38.8M	0.38%	53
2017 Q3	$48.1M	Sell	5,622 -600	-10%	-$49.2K	0.36%	67
2017 Q2	$51.2M	Sell	6,222 -105	-2%	-$8.57K	0.39%	65
2017 Q1	$53.2M	Buy	6,327 +5,720	+942%	+$458K	0.55%	38
2016 Q4	$4.46M	Buy	+607	New	+$45.2K	0.05%	275

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s LLY Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) reduced its Eli Lilly (LLY) stake by 76% in Q4 2019, selling an estimated $2.01M and leaving 5,389 shares worth $708K. The position accounts for 0.19% of the portfolio, ranked #49.

Arrowgrass Capital Partners (US) first reported a position in LLY in Q3 2013 and has held it in 9 quarters since. The position peaked at $6.69M in Q1 2017. 1,673 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

Arrowgrass Capital Partners (US) held 5,389 shares of Eli Lilly worth $708K as of Q4 2019.
Arrowgrass Capital Partners (US) sold 17,323 Eli Lilly shares in Q4 2019, an estimated $2.01M.
Eli Lilly made up 0.19% of Arrowgrass Capital Partners (US)'s portfolio in Q4 2019, its #49 holding.
Arrowgrass Capital Partners (US) first reported a position in Eli Lilly in Q3 2013 and has held it in 9 quarters since.
Arrowgrass Capital Partners (US)'s Eli Lilly position peaked at $6.69M in Q1 2017.
1,673 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.